Creator
Efforts to revamp the international response to the treatment of drug-resistant TB are not proving sufficient.
The successes of SA’s first public-sector ARV programme shows governments what can be achieved ahead of the United Nations High-Level Meeting on Aids.
Only 4% of South Africans living with HIV in South Africa are receiving preventative therapy for tuberculosis and only 1% are being screened for TB.
